Esther Prados de la Torre

8PUBLICATIONS
52CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCrop and pasture biomass and bioproductsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

|Jan 09, 2026
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry.

Esther Prados de la Torre, Josefina Serrano, Eva Barragán

|Mar 13, 2025
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.

Blanca Boluda, Rebeca Rodriguez-Veiga, Claudia Sargas

|Aug 12, 2023
Identification of Potential Bioactive Peptides in Sheep Milk Kefir through Peptidomic Analysis at Different Fermentation Times.

Sevim Dalabasmaz, Esther Prados de la Torre, Sabrina Gensberger-Reigl

|May 12, 2023
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.

Claudia Sargas, Rosa Ayala, María J Larráyoz

|Mar 11, 2023
Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

Clara Aparicio-Pérez, Esther Prados de la Torre, Joaquin Sanchez-Garcia

Pageof 2

Frequent Collaborators

4 joint publications

Claudia Sargas

3 joint publications

Juan Manuel Alonso-Domínguez

3 joint publications

María José Calasanz

3 joint publications

Esperanza Lavilla-Rubira